Osiris: Osiris Therapeutics : Amendment to a previously filed SC 14D9

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 1) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF...http://www.marketscreener.com/news/Osiris-Therapeutics-Amendment-to-a-previously-filed-SC-14D9--28249498/?utm_medium=RSS&utm_content=20190327